Anna Sjöström1,2, Johanna Dehlsen Wersäll2, Anna Warnqvist3, Maria Farm1,2, Maria Magnusson1,4,5, Anders Oldner6,7, Anna Ågren1,5,8, Jovan Antovic1,2, Maria Bruzelius1,5,9. 1. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. 2. Clinical Chemistry, Karolinska University Laboratory, Stockholm, Sweden. 3. Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. 4. Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. 5. Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden. 6. Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. 7. Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden. 8. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. 9. Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: High levels of D-dimer and low platelet counts are associated with poor outcome in coronavirus disease 2019 (COVID-19). As anticoagulation appeared to improve survival, hospital-wide recommendations regarding higher doses of anticoagulation were implemented on April 9, 2020. OBJECTIVES: To investigate if trends in D-dimer levels and platelet counts were associated with death, thrombosis, and the shift in anticoagulation. METHODS: Retrospective cohort study of 429 patients with COVID-19 at Karolinska University Hospital. Information on D-dimer levels and platelet counts was obtained from laboratory databases and clinical data from medical records. RESULTS: Thirty-day mortality and thrombosis rates were 19% and 18%, respectively. Pulmonary embolism was common, 65/83 (78%). Increased D-dimer levels in the first week in hospital were significantly associated with death and thrombosis (odds ratio [OR]: 6.06; 95% confidence interval [CL]: 2.10-17.5 and 3.11; 95% CI: 1.20-8.10, respectively). If platelet count increased more than 35 × 109/L per day, the mortality and thrombotic risk decreased (OR: 0.16; 95% CI: 0.06-0.41, and OR: 0.36; 95% CI: 0.17-0.80). After implementation of updated hospital-wide recommendations, the daily mean significantly decreased regarding D-dimer levels while platelet counts rose; -1.93; 95% CI: -1.00-2.87 mg/L FEU (fibrinogen-equivalent unit) and 65; 95% CI: 54-76 ×109/L, and significant risk reductions for death and thrombosis were observed; OR: 0.48; 95% CI: 0.25-0.92 and 0.35; 95% CI: 0.17-0.72. CONCLUSION: In contrast to D-dimer levels, increase of platelet count over the first week in hospital was associated with improved survival and reduced thrombotic risk. The daily mean levels of D-dimer dropped while the platelet counts rose, coinciding with increased anticoagulation and a decline in thrombotic burden and mortality. Thieme. All rights reserved.
BACKGROUND: High levels of D-dimer and low platelet counts are associated with poor outcome in coronavirus disease 2019 (COVID-19). As anticoagulation appeared to improve survival, hospital-wide recommendations regarding higher doses of anticoagulation were implemented on April 9, 2020. OBJECTIVES: To investigate if trends in D-dimer levels and platelet counts were associated with death, thrombosis, and the shift in anticoagulation. METHODS: Retrospective cohort study of 429 patients with COVID-19 at Karolinska University Hospital. Information on D-dimer levels and platelet counts was obtained from laboratory databases and clinical data from medical records. RESULTS: Thirty-day mortality and thrombosis rates were 19% and 18%, respectively. Pulmonary embolism was common, 65/83 (78%). Increased D-dimer levels in the first week in hospital were significantly associated with death and thrombosis (odds ratio [OR]: 6.06; 95% confidence interval [CL]: 2.10-17.5 and 3.11; 95% CI: 1.20-8.10, respectively). If platelet count increased more than 35 × 109/L per day, the mortality and thrombotic risk decreased (OR: 0.16; 95% CI: 0.06-0.41, and OR: 0.36; 95% CI: 0.17-0.80). After implementation of updated hospital-wide recommendations, the daily mean significantly decreased regarding D-dimer levels while platelet counts rose; -1.93; 95% CI: -1.00-2.87 mg/L FEU (fibrinogen-equivalent unit) and 65; 95% CI: 54-76 ×109/L, and significant risk reductions for death and thrombosis were observed; OR: 0.48; 95% CI: 0.25-0.92 and 0.35; 95% CI: 0.17-0.72. CONCLUSION: In contrast to D-dimer levels, increase of platelet count over the first week in hospital was associated with improved survival and reduced thrombotic risk. The daily mean levels of D-dimer dropped while the platelet counts rose, coinciding with increased anticoagulation and a decline in thrombotic burden and mortality. Thieme. All rights reserved.
Authors: Tanya K Marvi; William B Stubblefield; Benjamin F Tillman; Mark W Tenforde; Manish M Patel; Christopher J Lindsell; Wesley H Self; Carlos G Grijalva; Todd W Rice Journal: Crit Care Explor Date: 2022-01-18
Authors: Polina Len; Gaukhar Iskakova; Zarina Sautbayeva; Aigul Kussanova; Ainur T Tauekelova; Madina M Sugralimova; Anar S Dautbaeva; Meruert M Abdieva; Eugene D Ponomarev; Alexander Tikhonov; Makhabbat S Bekbossynova; Natasha S Barteneva Journal: Front Cardiovasc Med Date: 2022-03-11
Authors: Niklas Boknäs; Cia Laine; Andreas Hillarp; Ankit S Macwan; Kerstin M Gustafsson; Tomas L Lindahl; Margareta Holmström Journal: Thromb Res Date: 2022-03-18 Impact factor: 10.407